Company / Free Cash Flow per Share
Bionano Genomics, Inc. Free Cash Flow per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.86
FY2020
5-year range
-
FY2018-FY2020
Trend
+57.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-282.64 to $-0.86 over the past 2 years.
Based on SEC 10-K filings.
-0.86 in FY2020.
Improved from $-282.64 to $-0.86 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, free cash flow per share increased 57.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$0.86 | +57.2% |
| FY2019 | -$2.02 | +99.3% |
| FY2018 | -$282.64 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026